Zhejiang Yatai Pharmaceutical Co Ltd Asset Resilience Ratio
Zhejiang Yatai Pharmaceutical Co Ltd asset resilience ratio. Zhejiang Yatai Pharmaceutical Co Ltd (002370) has an Asset Resilience Ratio of 2.44% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Zhejiang Yatai Pharmaceutical Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Zhejiang Yatai Pharmaceutical Co Ltd (None–None)
Asset resilience ratio of Zhejiang Yatai Pharmaceutical Co Ltd from None to None. This chart shows how Zhejiang Yatai Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read 002370 liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Yatai Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Zhejiang Yatai Pharmaceutical Co Ltd (002370) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥30.06 Million | 2.44% |
| Total Liquid Assets | CN¥30.06 Million | 2.44% |
Asset Resilience Insights
- Limited Liquidity: Zhejiang Yatai Pharmaceutical Co Ltd maintains only 2.44% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Yatai Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhejiang Yatai Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 11.84% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Bide Pharmatech Co. Ltd. A
SHG:688073 |
Drug Manufacturers - Specialty & Generic | 9.46% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.42% |
Zhejiang Yatai Pharmaceutical Co Ltd Asset Resilience Ratio by Year (None–None)
Zhejiang Yatai Pharmaceutical Co Ltd asset resilience ratio by year from None to None. The table below shows the annual Asset Resilience Ratio data for Zhejiang Yatai Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| No yearly data available. | ||||
About Zhejiang Yatai Pharmaceutical Co Ltd
Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers solid dosage, cephalosporin powder injection, and freeze-dried powder injection products. It also provides various antibiotic and non-antibiotic drugs. The company was founded in 1989 and is based in Shaoxing, China.